Skip to main content
. Author manuscript; available in PMC: 2022 May 3.
Published in final edited form as: Cold Spring Harb Perspect Med. 2021 May 3;11(5):a034892. doi: 10.1101/cshperspect.a034892

Table 1.

Summary of the classification, pathological, and radiological features of the histiocytic neoplasms.

Disease LCH ECD JXG/AXG RDD ICH

Broad classification LCH Non-LCH Non-LCH Non-LCH Non-LCH
Revised classification groupings L L L (extracutaneous) and C (cutaneous) C (cutaneous) and R (other RDD) L
Immunophenotypic features
CD68 + ++ ++ ++ +
CD163 ++ ++ ++
CD14 ++ ++ ++
CD1a ++ ++
CD207 (Langerin) ++
S100 + −/+ −/+ + +
Factor XIIIa + + +
CD45 + + + + +
Histological features
Birbeck granules Yes No No No No
Xanthomatous histiocytes No Yes Yes No No
Touton giant cells No Yes Yes No No
Emperipolesis (intractyoplasmic lymphocytes) No Occasional Occasional Abundant No
Radiological features
Bilateral, symmetric osteosclerosis involving metadiaphysis of femur, tibia, and fibula Rare Frequent, pathognomonic No No No
Lytic, “punched-out” lesions of skull and axial skeleton Frequent Rare No No No
Infiltrative, perinephric soft tissue thickening (“hairy kidney”) No Frequent Rare No No

LCH, Langerhans cell histiocytosis; ECD, Erdheim−Chester disease; JXG, juvenile xanthogranuloma; AXG, adult xanthogranuloma; RDD, Rosai−Dorfman−Destombes disease; ICH, indeterminate cell histiocytosis; L group, Langerhansrelated; C group, cutaneous and mucocutaneous; R group, Rosai−Dorfman−Destombes disease; +, low expression; ++, high expression; −, no expression.